CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9800
+0.0293 (3.08%)
Apr 27, 2026, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $11.6 million as of April 28, 2026. Its market cap has decreased by -63.33% in one year.
Market Cap
11.60M
Enterprise Value
10.34M
1-Year Change
-63.33%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $11.60M, a decrease of -74.86%. That is a compound annual growth rate of -36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 11.60M | -24.73% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 11.78M |
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.59M |
| Reviva Pharmaceuticals Holdings | 11.53M |
| BioLineRx | 11.36M |
| BioVie | 11.31M |
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |